Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis C
Authors:
- Keyla Santos Guedes de SáKSKeyla Santos Guedes de Sá
- Ednelza da Silva Graça AmorasEAEdnelza da Silva Graça Amoras
- Simone Regina Souza da Silva CondeSCSimone Regina Souza da Silva Conde
- Maria Alice Freitas QueirozMQMaria Alice Freitas Queiroz
- Izaura Maria Vieira Cayres-VallinotoICIzaura Maria Vieira Cayres-Vallinoto
- Ricardo IshakRIRicardo Ishak
- Antonio Carlos Rosário VallinotoAntonio Carlos Rosário Vallinoto
Open Access
Abstract
An inefficient immune response against the hepatitis C virus (HCV), combined with viral evasion mechanisms, is responsible for the chronicity of infection. The need to evaluate the innate mechanisms of the immune response, such as TLR3 and IFN-λ3, and their relationship with the virus–host interaction is important for understanding the pathogenesis of chronic hepatitis C. The present study aimed to investigate the gene expressions of TRL3 and IFNL3 in liver tissue, seeking to evaluate whether these could be potential biomarkers of HCV infection. A total of 23 liver biopsy samples were collected from patients with chronic HCV, and 8 biopsies were collected from healthy control patients. RNA extraction, reverse transcription and qPCR were performed to quantify the relative gene expressions of TLR3 and IFNL3. Data on the viral load; AST, ALT, GGT and AFP levels; and the viral genotype were collected from the patients′ medical records. The intrahepatic expression of TLR3 (p = 0.0326) was higher in chronic HCV carriers than in the control group, and the expression of IFNL3 (p = 0.0037) was lower in chronic HCV carriers than in the healthy control group. The expression levels of TLR3 (p = 0.0030) and IFNL3 (p = 0.0036) were higher in the early stages of fibrosis and of necroinflammatory activity in the liver; in contrast, TLR3 and IFNL3 expressions were lower in the more advanced stages of fibrosis and inflammation. There was no correlation between the gene expression and the serum viral load. Regarding the initial METAVIR scale scores, liver transaminase levels were lower in patients with advanced fibrosis when correlated with TLR3 and IFNL3 gene expressions. The results suggest that in the early stages of the development of hepatic fibrosis, TLR3 and IFN-λ3 play important roles in the antiviral response and in the modulation of the tolerogenic liver environment because there is a decrease in the intrahepatic expressions of TLR3 and IFNL3 in the advanced stages of fibrosis, probably due to viral evasion mechanisms.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#480128/2013-8, #301869/2017-0)
This publication has 40 references indexed in Scilit:
- Interleukin 28B Gene Polymorphisms and Epstein-Barr Virus-Associated Lymphoproliferative DiseasesIntervirology, 2014
- Involvement of Differential Relationship between HCV Replication and Hepatic PRR Signaling Gene Expression in Responsiveness to IFN-Based TherapyHepatitis Research and Treatment, 2013
- In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C.2013
- NFκB, cytokines, TLR 3 and 7 expression in human end‐stage HCV and alcoholic liver diseaseEuropean Journal of Clinical Investigation, 2010
- Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma CellsJournal of Virology, 2009
- Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of MacrophagesJournal of Virology, 2009
- Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expressionVirology Journal, 2006
- Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFProceedings of the National Academy of Sciences, 2005
- Involvement of natural killer cells in PolyI:C-induced liver injuryJournal of Hepatology, 2004
- Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine ProteaseScience, 2003